Search Results
6. LI-RADS: Malignant lesions that are not definitely HCC: LR-M - Part 2 (Q&A). Dr. Kathryn Fowler.
5. LI-RADS: Malignant lesions that are not definitely HCC: LR-M - Part 1. By Dr. Kathryn Fowler.
What’s New in LI-RADS?-- Kathryn Fowler, MD (SABI 42nd Annual Course)
4. LI-RADS: Overview of CT/MR algorithm and major features - Part 2 (Q&A). By Dr. Victoria Chernyak.
12. Pitfalls in Cirrhosis Imaging and User Errors in applying LI-RADS - Part 2. Dr. Khaled Elsayes
14. LI-RADS: HCC Treatment Response: from Concepts to Algorithms - Part 2 (Q&A). By Dr. Richard Do.
8. LI-RADS; LR- Tumor In Vein (TIV) - Part 2 (Q&A). By Dr. Alessandro Furlan.
10. LI-RADS Ancillary Features - Part 2 (Q&A). By Dr. James Lee
11. Pitfalls in Cirrhosis Imaging and User Errors in applying LI-RADS - Part 1. Dr. Khaled Elsayes
46. Liver malignancy masquerading as benignancy and how LI-RADS fits in-Part 1. By Dr. William Masch
Claude-athon 2018 (pt 6): Liver Lesions - Algorithmic Approach for Differential Diagnosis
Claude-athon 2018 (pt 7): Introduction to LI-RADS
